Helicobacter pylori infection as a model for gastrointestinal immunity and chronic inflammatory diseases

被引:26
作者
Ernst, PB [1 ]
Takaishi, H [1 ]
Crowe, SE [1 ]
机构
[1] Univ Virginia, Dept Internal Med, Div Gastroenterol & Hepatol, Charlottesville, VA 22908 USA
关键词
cytokines; immunity; bacteria; immunopathogenesis; T cells; vaccines; inflammatory bowel disease;
D O I
10.1159/000050663
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Approximately 50% of humanity is infected with Helicobacter pylori. It is a life-long infection that elicits a marked host inflammatory response; however, natural infection fails to yield protective immunity. Rather than providing protection, the chronic inflammatory response associated with natural infection contributes to tissue damage and the pathogenesis of gastroduodenal disease, including atrophic gastritis, peptic ulcer, and gastric cancer. While bacterial factors are important triggers of inflammation, many subjects infected with strains bearing putative virulence factors remain free from disease. Recent genetic studies have implicated the host's immune and inflammatory responses, suggesting that disease results from an interaction between bacterial and environmental factors in genetically susceptible hosts. Other digestive diseases, including celiac disease and inflammatory bowel disease, mimic this paradigm, where it appears that luminal triggers only manifest disease in subjects with the right combination of host and environmental factors. Since infection with H. pylori is relatively common, it is possible to study the impact of a specific etiologic agent on the pathogenesis of disease in humans. This approach has illuminated the complexity of the pathogenic mechanisms, but the advances achieved to date may provide some hints regarding the pathogenesis of chronic inflammatory diseases elsewhere in the digestive tract. Copyright (C) 2001 S. Karger AG, Basel.
引用
收藏
页码:104 / 111
页数:8
相关论文
共 88 条
[1]   Bugs on trial:: the case of Helicobacter pylori and autoimmunity [J].
Appelmelk, BJ ;
Faller, G ;
Claeys, D ;
Kirchner, T ;
Vandenbroucke-Grauls, CMJE .
IMMUNOLOGY TODAY, 1998, 19 (07) :296-299
[2]   Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype [J].
Bamford, KB ;
Fan, XJ ;
Crowe, SE ;
Leary, JF ;
Gourley, WK ;
Luthra, GK ;
Brooks, EG ;
Graham, DY ;
Reyes, VE ;
Ernst, PB .
GASTROENTEROLOGY, 1998, 114 (03) :482-492
[3]   Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis [J].
Berstad, AE ;
Brandtzaeg, P ;
Stave, R ;
Halstensen, TS .
GUT, 1997, 40 (02) :196-203
[4]   Complement activation directly induced by Helicobacter pylori [J].
Berstad, AE ;
Hogåsen, K ;
Bukholm, G ;
Moran, AP ;
Brandtzaeg, P .
GASTROENTEROLOGY, 2001, 120 (05) :1108-1116
[5]   Antibody-independent protective mucosal immunity to gastric Helicobacter infection in mice [J].
Blanchard, TG ;
Czinn, SJ ;
Redline, RW ;
Sigmund, N ;
Harriman, G ;
Nedrud, JG .
CELLULAR IMMUNOLOGY, 1999, 191 (01) :74-80
[6]   Helicobacter pylori lipopolysaccharide binds to CD14 and stimulates release of interleukin-8, epithelial neutrophil-activating peptide 78, and monocyte chemotactic protein 1 by human monocytes [J].
Bliss, CM ;
Golenbock, DT ;
Keates, S ;
Linevsky, JK ;
Kelly, CP .
INFECTION AND IMMUNITY, 1998, 66 (11) :5357-5363
[7]   Helicobacter pylori infections in IgA deficiency: Lack of role for the secretory immune system [J].
Bogstedt, AK ;
Nava, S ;
Wadstrom, T ;
Hammarstrom, L .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (02) :202-204
[8]  
Brandtzaeg P., 1986, BASIC SCI GASTROENTE, P179
[9]   IMMUNIZATION AGAINST GASTRIC HELICOBACTER INFECTION IN A MOUSE HELICOBACTER-FELIS MODEL [J].
CHEN, MH ;
LEE, A ;
HAZELL, S .
LANCET, 1992, 339 (8801) :1120-1121
[10]   Colonic bacteria express an ulcerative colitis pANCA-related protein epitope [J].
Cohavy, O ;
Bruckner, D ;
Gordon, LK ;
Misra, R ;
Wei, B ;
Eggena, ME ;
Targan, SR ;
Braun, J .
INFECTION AND IMMUNITY, 2000, 68 (03) :1542-1548